A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
University of Alabama at Birmingham
Soligenix
Prescient Therapeutics, Ltd.
National Institutes of Health Clinical Center (CC)
Abramson Cancer Center at Penn Medicine
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
Fondazione Italiana Linfomi - ETS
Fondazione Italiana Linfomi - ETS
Institute of Hematology & Blood Diseases Hospital, China
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Assistance Publique - Hôpitaux de Paris
Kyowa Kirin Co., Ltd.
Columbia University
SciTech Development, Inc.
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Fondazione Italiana Linfomi - ETS
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
Instituto de Investigación Biomédica de Salamanca
Lund University Hospital
University College, London
Innate Pharma
Assistance Publique - Hôpitaux de Paris
4SC AG
Emory University
University of Pittsburgh
Peking University First Hospital
Indiana University
Northwestern University
City of Hope Medical Center
European Organisation for Research and Treatment of Cancer - EORTC
Wake Forest University Health Sciences
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)